Safety of long-term interruption of successful antiretroviral therapy: the ATHENA cohort study

Ferdinand W. N. M. Wit, Daniel H. Blanckenberg, Kees Brinkman, Jan M. Prins, Marchina E. van der Ende, Margriet M. E. Schneider, Jan-Willem Mulder, Frank de Wolf, Joep M. A. Lange

Research output: Contribution to journalArticleAcademicpeer-review

34 Citations (Scopus)

Abstract

We studied the dynamics of CD4 cell counts after the interruption of virologically successful highly active antiretroviral therapy (HAART) in 139 patients. Changes in CD4 cell counts during HAART interruption followed a biphasic pattern: an initial rapid decline during the first month followed by a slow decrease. During 48 weeks of follow-up mean CD4 cell counts remained just above the mean pre-HAART level. This limits the feasibility of structured treatment interruptions for patients with low nadir CD4 cell counts
Original languageEnglish
Pages (from-to)345-348
JournalAIDS (London, England)
Volume19
Issue number3
Publication statusPublished - 2005

Cite this